New York – May 30th, 2019 – Creative Bioarray, a world’s leading biotechnology products and services provider, recently announced the release of its comprehensive exosome isolation tools to support exosome research and resolves issues quickly and efficiently. With this release, Creative Bioarray also offers customized exsome-related services to satisfy specific needs.
At present, related studies indicate that exosomal proteins may potentially be used as biomarkers for disease diagnosis. Antibodies are important tools for scientists in the study of exosomes and diagnostics. Exosomal antibodies detect exosome-specific proteins and can help study the relationship between exosomes and diseases. Creative Bioarray offers a list of monoclonal/polyclonal antibodies against common and disease-specific exosome proteins. These antibodies are suitable for common applications including WB, ELISA, FC, IHC, ICC, IF, IP, etc. Meanwhile, we are constantly developing more exosome antibodies to meet the needs of our customers.
Besides, exosomal isolation is critical in the study of exosomes. The purity and yield of exosomes often affect the outcome. However, it is still technically challenging to achieve great isolation. Creative Bioarray aims to develop the best quality exosome isolation tools with optimized conditions to help our customers achieve higher yields of pure exosomes. We offer a wide range of ExoQuali products and protocols to guarantee easier and more efficient isolation than ever. Our exosome isolation tools successfully separate and enrich intact exosomes from a variety of body fluids, including cell culture media, serum, plasma, urine, saliva and other biological fluids. Complete exosomes isolated by our isolated products can be further used for characterization studies, exosome subpopulations, qRT-PCR analysis, exosome high-throughput sequencing, ELISA, exosomal labeling, WB analysis of exosomal proteins, co-culture experiments and exosome-based analysis.
Exosomes contain RNA (miRNAs and mRNAs) that regulate the different cellular functions in recipient cells by transmitting signals that are critical for cell-cell communication. There is no doubt that miRNAs and mRNA carry a wealth of information that facilitates the development of potential biomarkers for early diagnosis of disease, such as identifying tumor types and monitoring their progression.
“Creative Bioarray aims to develop the best quality exosome extraction kits with optimized conditions to help our customers achieve higher yields of pure exosomes. Our newly developed Exosome RNA extraction kits and reagents are designed for high quality purification, separation and extraction of total RNA (miRNA + mRNA),” said Hannah Cole, the marketing director of Creative Bioarray.
About Creative Bioarray
Founded in 2005, Creative Bioarray is the state-of-art biotechnology provider to satisfy researchers with high quality services and cutting-edge products. Creative Bioarray, as a well-recognized industry leader who aims to utilize the latest technology or proprietary protocols to authenticate and develop quality products that drive innovation and standards in science for more than a decades, already supported millions of researchers worldwide.
Media ContactCompany Name: Creative BioarrayContact Person: Hannah ColeEmail: Send EmailPhone: 1-631-619-7922Address:45-1 Ramsey Road Shirley City: Long Island CityState: New YorkCountry: United StatesWebsite: http://www.creative-bioarray.com
